Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing [Yahoo! Finance]
Dyne Therapeutics, Inc. (DYN)
Last dyne therapeutics, inc. earnings: 11/1 04:30 pm
Check Earnings Report
US:NYSE Investor Relations:
dynegy.com/investors/presentations-events
Company Research
Source: Yahoo! Finance
Palo Alto Investors LP disclosed an increase of 209,523 shares in Dyne Therapeutics (NASDAQ:DYN) in its 13F filing for the quarter ended December 31, 2025, an estimated $3.97 million trade based on quarterly average pricing. What Happened Palo Alto Investors LP reported an increase of 209,523 shares in Dyne Therapeutics according to an SEC filing dated February 17, 2026. The estimated value of this trade was $3.97 million, calculated using the average closing price for the quarter. The fund's quarter-end position in the company increased in value by $12.82 million, a figure that includes both additional shares and price appreciation. What Else to Know Palo Alto Investors LP's buy lifts its Dyne Therapeutics stake to 4.01% of reported 13F AUM. Top five holdings after the filing: NASDAQ:INSM: $85.19 million (11.9% of AUM) NASDAQ:FOLD: $74.13 million (10.3% of AUM) NASDAQ:PTCT: $68.66 million (9.6% of AUM) NASDAQ:ACAD: $66.35 million (9.2% of AUM) NASDAQ:BMRN: $44.35
Show less
Read more
Impact Snapshot
Event Time:
DYN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DYN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DYN alerts
High impacting Dyne Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
DYN
News
- Dyne Therapeutics (DYN) had its "overweight" rating reaffirmed by Morgan Stanley.MarketBeat
- Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
- Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business HighlightsGlobeNewswire
- Dyne Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Dyne Therapeutics to Participate in Upcoming Investor ConferencesGlobeNewswire
DYN
Earnings
- 3/2/26 - Miss
DYN
Sec Filings
- 3/2/26 - Form S-8
- 3/2/26 - Form 8-K
- 3/2/26 - Form 10-K
- DYN's page on the SEC website